Sodium Intake Regulates Glucose Homeostasis through the PPARδ/Adiponectin-Mediated SGLT2 Pathway

Cell Metabolism

Volumn 23, Issue 4, 2016, Pages 699-711

  Zhao, Yu ^a   Gao, Peng ^a   Sun, Fang ^a   Li, Qiang ^a   Chen, Jing ^a   Yu, Hao ^a   Li, Li ^a   Wei, Xing ^a   He, Hongbo ^a   Lu, Zongshi ^a   Wei, Xiao ^a   Wang, Bin ^a   Cui, Yuanting ^a   Xiong, Shiqiang ^a   Shang, Qianhui ^b   Xu, Aimin ^c   Huang, Yu ^d   Liu, Daoyan ^a   Zhu, Zhiming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b ZUNYI MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALDOSTERONE; GLUCOSE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; SODIUM; SODIUM GLUCOSE COTRANSPORTER 2;

ADIPOSE TISSUE; ALDOSTERONE BLOOD LEVEL; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLUCOSE URINE LEVEL; GLUCOSURIA; HIGH SODIUM INTAKE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; MOUSE; NATRIURESIS; NONHUMAN; PERIRENAL FAT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SODIUM EXCRETION; SODIUM INTAKE; SODIUM METABOLISM; SODIUM TRANSPORT; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; TRANSCRIPTION INITIATION; URINE VOLUME; ANIMAL; BLOOD; CELL LINE; HOMEOSTASIS; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; SIGNAL TRANSDUCTION;

ADIPONECTIN; ANIMALS; BLOOD GLUCOSE; CELL LINE; DIABETES MELLITUS, TYPE 2; HOMEOSTASIS; HUMANS; HYPERGLYCEMIA; MICE; PPAR DELTA; SIGNAL TRANSDUCTION; SODIUM, DIETARY; SODIUM-GLUCOSE TRANSPORTER 2;

EID: 84963706055     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2016.02.019     Document Type: Article

References (55)

1. H.J. Adrogué, and N.E. Madias Sodium and potassium in the pathogenesis of hypertension N. Engl. J. Med. 356 2007 1966 1978
2. M. Ahmadian, J.M. Suh, N. Hah, C. Liddle, A.R. Atkins, M. Downes, and R.M. Evans PPARγ signaling and metabolism: the good, the bad and the future Nat. Med. 19 2013 557 566
3. E.Z. Amri, F. Bonino, G. Ailhaud, N.A. Abumrad, and P.A. Grimaldi Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors J. Biol. Chem. 270 1995 2367 2371
4. J.P. Bantle, J. Wylie-Rosett, A.L. Albright, C.M. Apovian, N.G. Clark, M.J. Franz, B.J. Hoogwerf, A.H. Lichtenstein, E. Mayer-Davis, A.D. Mooradian, M.L. Wheeler American Diabetes Association Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association Diabetes Care 31 Suppl 1 2008 S61 S78
5. Y. Barak, D. Liao, W. He, E.S. Ong, M.C. Nelson, J.M. Olefsky, R. Boland, and R.M. Evans Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer Proc. Natl. Acad. Sci. USA 99 2002 303 308
6. K.M. Boini, A.M. Hennige, D.Y. Huang, B. Friedrich, M. Palmada, C. Boehmer, F. Grahammer, F. Artunc, S. Ullrich, D. Avram, and et al. Serum- and glucocorticoid-inducible kinase 1 mediates salt sensitivity of glucose tolerance Diabetes 55 2006 2059 2066
7. K.C. Choi, S.Y. Lee, H.J. Yoo, O.H. Ryu, K.W. Lee, S.M. Kim, S.H. Baik, and K.M. Choi Effect of PPAR-delta agonist on the expression of visfatin, adiponectin, and resistin in rat adipose tissue and 3T3-L1 adipocytes Biochem. Biophys. Res. Commun. 357 2007 62 67
8. M. Collino, E. Benetti, G. Miglio, S. Castiglia, A.C. Rosa, M. Aragno, C. Thiemermann, and R. Fantozzi Peroxisome proliferator-activated receptor β/δ agonism protects the kidney against ischemia/reperfusion injury in diabetic rats Free Radic. Biol. Med. 50 2011 345 353
9. J.J. DiNicolantonio, and S.C. Lucan The wrong white crystals: not salt but sugar as aetiological in hypertension and cardiometabolic disease Open Heart 1 2014 e000167
10. E.I. Ekinci, S. Clarke, M.C. Thomas, J.L. Moran, K. Cheong, R.J. MacIsaac, and G. Jerums Dietary salt intake and mortality in patients with type 2 diabetes Diabetes Care 34 2011 703 709
11. H.S. Freitas, G.F. Anhê, K.F. Melo, M.M. Okamoto, M. Oliveira-Souza, S. Bordin, and U.F. Machado Na(+) -glucose transporter-2 messenger ribonucleic acid expression in kidney of diabetic rats correlates with glycemic levels: involvement of hepatocyte nuclear factor-1alpha expression and activity Endocrinology 149 2008 717 724
12. P. Gao, T.T. Xu, J. Lu, L. Li, J. Xu, D.L. Hao, H.Z. Chen, and D.P. Liu Overexpression of SIRT1 in vascular smooth muscle cells attenuates angiotensin II-induced vascular remodeling and hypertension in mice J. Mol. Med. 92 2014 347 357
13. J.E. Gerich Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications Diabet. Med. 27 2010 136 142
14. Y. Guan, C. Hao, D.R. Cha, R. Rao, W. Lu, D.E. Kohan, M.A. Magnuson, R. Redha, Y. Zhang, and M.D. Breyer Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption Nat. Med. 11 2005 861 866
15. S. Han, D.L. Hagan, J.R. Taylor, L. Xin, W. Meng, S.A. Biller, J.R. Wetterau, W.N. Washburn, and J.M. Whaley Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats Diabetes 57 2008 1723 1729
16. F.J. He, and G.A. MacGregor Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials Lancet 378 2011 380 382
17. W. He, Y. Barak, A. Hevener, P. Olson, D. Liao, J. Le, M. Nelson, E. Ong, J.M. Olefsky, and R.M. Evans Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle Proc. Natl. Acad. Sci. USA 100 2003 15712 15717
18. H. He, D. Yang, L. Ma, Z. Luo, S. Ma, X. Feng, T. Cao, Z. Yan, D. Liu, M. Tepel, and Z. Zhu Telmisartan prevents weight gain and obesity through activation of peroxisome proliferator-activated receptor-delta-dependent pathways Hypertension 55 2010 869 879
19. X. Hui, K.S. Lam, P.M. Vanhoutte, and A. Xu Adiponectin and cardiovascular health: an update Br. J. Pharmacol. 165 2012 574 590
20. M. Imanishi, K. Yoshioka, M. Okumura, Y. Konishi, N. Okada, T. Morikawa, T. Sato, S. Tanaka, and S. Fujii Sodium sensitivity related to albuminuria appearing before hypertension in type 2 diabetic patients Diabetes Care 24 2001 111 116
21. M.J. Jurczak, H.Y. Lee, A.L. Birkenfeld, F.R. Jornayvaz, D.W. Frederick, R.L. Pongratz, X. Zhao, G.W. Moeckel, V.T. Samuel, J.M. Whaley, and et al. SGLT2 deletion improves glucose homeostasis and preserves pancreatic beta-cell function Diabetes 60 2011 890 898
22. T. Kadowaki, T. Yamauchi, N. Kubota, K. Hara, K. Ueki, and K. Tobe Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome J. Clin. Invest. 116 2006 1784 1792
23. Y. Kamari, N. Shimoni, F. Koren, E. Peleg, Y. Sharabi, and E. Grossman High-salt diet increases plasma adiponectin levels independent of blood pressure in hypertensive rats: the role of the renin-angiotensin-aldosterone system J. Hypertens. 28 2010 95 101
24. Y. Kanai, W.S. Lee, G. You, D. Brown, and M.A. Hediger The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose J. Clin. Invest. 93 1994 397 404
25. D.E. Kohan, P. Fioretto, W. Tang, and J.F. List Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control Kidney Int. 85 2014 962 971
26. R.K. Kothinti, A.B. Blodgett, D.H. Petering, and N.M. Tabatabai Cadmium down-regulation of kidney Sp1 binding to mouse SGLT1 and SGLT2 gene promoters: possible reaction of cadmium with the zinc finger domain of Sp1 Toxicol. Appl. Pharmacol. 244 2010 254 262
27. C.H. Lee, A. Chawla, N. Urbiztondo, D. Liao, W.A. Boisvert, R.M. Evans, and L.K. Curtiss Transcriptional repression of atherogenic inflammation: modulation by PPARdelta Science 302 2003 453 457
28. L. Li, Z. Luo, H. Yu, X. Feng, P. Wang, J. Chen, Y. Pu, Y. Zhao, H. He, J. Zhong, and et al. Telmisartan improves insulin resistance of skeletal muscle through peroxisome proliferator-activated receptor-δ activation Diabetes 62 2013 762 774
29. R.P. Lifton, A.G. Gharavi, and D.S. Geller Molecular mechanisms of human hypertension Cell 104 2001 545 556
30. L.H. Lindholm, H. Ibsen, B. Dahlöf, R.B. Devereux, G. Beevers, U. de Faire, F. Fyhrquist, S. Julius, S.E. Kjeldsen, K. Kristiansson, et al. LIFE Study Group Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Lancet 359 2002 1004 1010
31. K. Ma, A. Cabrero, P.K. Saha, H. Kojima, L. Li, B.H. Chang, A. Paul, and L. Chan Increased beta -oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin J. Biol. Chem. 277 2002 34658 34661
32. A. Mather, and C. Pollock Glucose handling by the kidney Kidney Int. Suppl. 79 Suppl 120 2011 S1 S6
33. Y. Matsushita, D. Ogawa, J. Wada, N. Yamamoto, K. Shikata, C. Sato, H. Tachibana, N. Toyota, and H. Makino Activation of peroxisome proliferator-activated receptor delta inhibits streptozotocin-induced diabetic nephropathy through anti-inflammatory mechanisms in mice Diabetes 60 2011 960 968
34. D. Mozaffarian, S. Fahimi, G.M. Singh, R. Micha, S. Khatibzadeh, R.E. Engell, S. Lim, G. Danaei, M. Ezzati, J. Powles Global Burden of Diseases Nutrition and Chronic Diseases Expert Group Global sodium consumption and death from cardiovascular causes N. Engl. J. Med. 371 2014 624 634
35. G. Musso, R. Gambino, M. Cassader, and G. Pagano A novel approach to control hyperglycemia in type 2 diabetes: sodium glucose co-transport (SGLT) inhibitors: systematic review and meta-analysis of randomized trials Ann. Med. 44 2012 375 393
36. R. Negro, G. Formoso, and H. Hassan The effects of irbesartan and telmisartan on metabolic parameters and blood pressure in obese, insulin resistant, hypertensive patients J. Endocrinol. Invest. 29 2006 957 961
37. J.A. O'Hare, J.B. Ferriss, D. Brady, B. Twomey, and D.J. O'Sullivan Exchangeable sodium and renin in hypertensive diabetic patients with and without nephropathy Hypertension 7 1985 II43 II48
38. T. Ogihara, T. Asano, K. Ando, H. Sakoda, M. Anai, N. Shojima, H. Ono, Y. Onishi, M. Fujishiro, M. Abe, and et al. High-salt diet enhances insulin signaling and induces insulin resistance in Dahl salt-sensitive rats Hypertension 40 2002 83 89
39. H. Osorio, R. Bautista, A. Rios, M. Franco, J. Santamaría, and B. Escalante Effect of treatment with losartan on salt sensitivity and SGLT2 expression in hypertensive diabetic rats Diabetes Res. Clin. Pract. 86 2009 e46 e49
40. H. Rahmoune, P.W. Thompson, J.M. Ward, C.D. Smith, G. Hong, and J. Brown Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes Diabetes 54 2005 3427 3434
41. R.S. Rosenson, R.S. Wright, M. Farkouh, and J. Plutzky Modulating peroxisome proliferator-activated receptors for therapeutic benefit? Biology, clinical experience, and future prospects Am. Heart J. 164 2012 672 680
42. J.R. Sowers, M. Epstein, and E.D. Frohlich Diabetes, hypertension, and cardiovascular disease: an update Hypertension 37 2001 1053 1059
43. P. Strazzullo, L. D'Elia, N.B. Kandala, and F.P. Cappuccio Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies BMJ 339 2009 b4567
44. N.M. Tabatabai, M. Sharma, S.S. Blumenthal, and D.H. Petering Enhanced expressions of sodium-glucose cotransporters in the kidneys of diabetic Zucker rats Diabetes Res. Clin. Pract. 83 2009 e27 e30
45. A. Tenenbaum, M. Motro, and E.Z. Fisman Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons Cardiovasc. Diabetol. 4 2005 14
46. M.C. Thomas, J. Moran, C. Forsblom, V. Harjutsalo, L. Thorn, A. Ahola, J. Wadén, N. Tolonen, M. Saraheimo, D. Gordin, P.H. Groop FinnDiane Study Group The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes Diabetes Care 34 2011 861 866
47. M.C. Thomas, K.A. Jandeleit-Dahm, and C. Tikellis The renoprotective actions of peroxisome proliferator-activated receptors agonists in diabetes PPAR Res. 2012 2012 456529
48. V. Vallon, K.A. Platt, R. Cunard, J. Schroth, J. Whaley, S.C. Thomson, H. Koepsell, and T. Rieg SGLT2 mediates glucose reabsorption in the early proximal tubule J. Am. Soc. Nephrol. 22 2011 104 112
49. V. Vallon, M. Rose, M. Gerasimova, J. Satriano, K.A. Platt, H. Koepsell, R. Cunard, K. Sharma, S.C. Thomson, and T. Rieg Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus Am. J. Physiol. Renal Physiol. 304 2013 F156 F167
50. M. Vedovato, G. Lepore, A. Coracina, A.R. Dodesini, E. Jori, A. Tiengo, S. Del Prato, and R. Trevisan Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance Diabetologia 47 2004 300 303
51. H.M. Wadei, and S.C. Textor The role of the kidney in regulating arterial blood pressure Nat. Rev. Nephrol. 8 2012 602 609
52. Y.X. Wang, C.H. Lee, S. Tiep, R.T. Yu, J. Ham, H. Kang, and R.M. Evans Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity Cell 113 2003 159 170
53. J.H. Warram, L.M. Laffel, P. Valsania, A.R. Christlieb, and A.S. Krolewski Excess mortality associated with diuretic therapy in diabetes mellitus Arch. Intern. Med. 151 1991 1350 1356
54. T. Yamauchi, J. Kamon, H. Waki, Y. Terauchi, N. Kubota, K. Hara, Y. Mori, T. Ide, K. Murakami, N. Tsuboyama-Kasaoka, and et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nat. Med. 7 2001 941 946
55. L.L. Zhang, D. Yan Liu, L.Q. Ma, Z.D. Luo, T.B. Cao, J. Zhong, Z.C. Yan, L.J. Wang, Z.G. Zhao, S.J. Zhu, and et al. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity Circ. Res. 100 2007 1063 1070